Cargando…
An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function
Inhaled substances, such as consumer products, chemicals at the workplace, and nanoparticles, can affect the lung function in several ways. In this paper, we explore the adverse outcome pathway (AOP) that starts when inhaled substances that reach the alveoli inhibit the function of the lung surfacta...
Autores principales: | Da Silva, Emilie, Vogel, Ulla, Hougaard, Karin S., Pérez-Gil, Jesus, Zuo, Yi Y., Sørli, Jorid B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320609/ https://www.ncbi.nlm.nih.gov/pubmed/34345865 http://dx.doi.org/10.1016/j.crtox.2021.05.005 |
Ejemplares similares
-
Molecular and biophysical mechanisms behind the enhancement of lung surfactant function during controlled therapeutic hypothermia
por: Autilio, C., et al.
Publicado: (2021) -
Author Correction: Molecular and biophysical mechanisms behind the enhancement of lung surfactant function during controlled therapeutic hypothermia
por: Autilio, C., et al.
Publicado: (2021) -
Plethysmograph training: A refinement for collection of respiration data in mice
por: Sørli, Jorid B., et al.
Publicado: (2023) -
Decreased surfactant lipids correlate with lung function in chronic obstructive pulmonary disease (COPD)
por: Agudelo, Christina W., et al.
Publicado: (2020) -
Polyhydroxyalkanoate Nanoparticles for Pulmonary Drug Delivery: Interaction with Lung Surfactant
por: Cañadas, Olga, et al.
Publicado: (2021)